Excessive mural calcium overload — A predominant causal factor in the development of stenosing coronary plaques in humans
- 1 September 1990
- journal article
- research article
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 4 (S5) , 1005-1013
- https://doi.org/10.1007/bf02018309
Abstract
Healthy human coronary artery walls contain, over their entire lifetime, more free and total cholesterol than calcium. However, as soon as arteriosclerotic alterations set in, the calcium content increases. Thus in coronary fatty streaks (arteriosclerotic plaques of WHO stage I), calcium was increased 13 times, in stage II plaques 25 times, and in fully developed stage III plaques 80 times above normal on average. The most dramatic calcium incrustation was found in coronary stage III plaques that had produced massive fatal coronary infarction. Here, the proportion of calcium salts (particularly hydroxyapatite) may amount to almost 50% of dry weight. Thus the most excessive accumulation of calcium seems to be correlated with the highest fatality. In contrast, there is no correlation between mural coronary free or total cholesterol content, and plaque severity. Accordingly, stenosing coronary stage III plaques contain less cholesterol than do fatty streaks. Moreover, in coronary stage III plaques the proportion of free cholesterol was 1.37%, and of total cholesterol only 2.34% of the whole mass, certainly not enough for directly causing coronary occlusion. Thus the calcium-rich plaques of human coronary arteries considerably differ from the well-known cholesterol-rich plaques (stage I and II) of human aortae. Our findings justify a new prophylactic approach with suitable calcium antagonists, to interfere with deleterious calcium uptake in coronary plaque development.Keywords
This publication has 19 references indexed in Scilit:
- Can the Progression of Coronary Sclerosis Be Influenced by Calcium Antagonists?Journal of Cardiovascular Pharmacology, 1989
- George Lyman Duff memorial lecture. Progression and regression of atherosclerotic lesions. Insights from lipid physical biochemistry.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
- The role of calcium in the pathogenesis of experimental arteriosclerosisTrends in Pharmacological Sciences, 1987
- Model experiments on anticalcinotic and antiarteriosclerotic arterial protection with calcium antagonistsJournal of Molecular and Cellular Cardiology, 1987
- Antiatherogenic properties of calcium antagonistsThe American Journal of Cardiology, 1987
- Future directions in the use of calcium antagonistsThe American Journal of Cardiology, 1987
- Antihypertensive and arterial anticalcinotic effects of calcium antagonistsThe American Journal of Cardiology, 1986
- Experimental basis of the long-term therapy of arterial hypertension with calcium antagonistsThe American Journal of Cardiology, 1985
- Specific Pharmacology of Calcium in Myocardium, Cardiac Pacemakers, and Vascular Smooth MuscleAnnual Review of Pharmacology and Toxicology, 1977
- Factors affecting arterial calcification associated with atherosclerosis: A reviewAtherosclerosis, 1972